Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prime Medicine (PRME) Retained Earnings (2021 - 2025)

Prime Medicine filings provide 5 years of Retained Earnings readings, the most recent being $82000.0 for Q4 2025.

  • On a quarterly basis, Retained Earnings rose 8100.0% to $82000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $82000.0, a 8100.0% increase, with the full-year FY2025 number at $82000.0, up 8100.0% from a year prior.
  • Retained Earnings hit $82000.0 in Q4 2025 for Prime Medicine, up from $33000.0 in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of $82000.0 in Q4 2025 to a low of -$791.7 million in Q2 2025.
  • Median Retained Earnings over the past 5 years was -$253.9 million (2022), compared with a mean of -$289.2 million.
  • The widest YoY moves for Retained Earnings: up 8100.0% in 2025, down 1114970.42% in 2025.
  • Prime Medicine's Retained Earnings stood at -$171.4 million in 2021, then surged by 99.78% to -$384000.0 in 2022, then plummeted by 127850.52% to -$491.3 million in 2023, then surged by 100.0% to $1000.0 in 2024, then soared by 8100.0% to $82000.0 in 2025.
  • The last three reported values for Retained Earnings were $82000.0 (Q4 2025), $33000.0 (Q3 2025), and -$791.7 million (Q2 2025) per Business Quant data.